Post-gastric cancer surgery hypophysitis and cortisol insufficiency after immunotherapy: a case series

Abstract Background Gastric cancer is one of the most prevalent and deadly malignancies worldwide. In recent years, with the development of immune checkpoint inhibitors (such as PD-1/PD-L1 and CTLA-4 inhibitors), immunotherapy has emerged as a new strategy in gastric cancer treatment. However, the incidence of immune-related adverse events (irAEs) has also increased. Here, we report eleven cases of gastric cancer patients who developed pituitary or adrenal cortisol insufficiency in the first postoperative week following neoadjuvant immunotherapy. Case presentation We present a retrospective analysis of patients who underwent surgical resection for gastric cancer at our center starting from December 2023. We evaluated their perioperative cortisol function and identified those who developed perioperative cortisol insufficiency, and identified eleven gastric cancer patients with normal cortisol functions who had received neoadjuvant immunotherapy, and subsequently experienced postoperative changes within a short period following surgery. Among them, six patients showed decreased ACTH and cortisol levels, four patients had reduced cortisol levels, and one patient with no ACTH testing also showed reduced cortisol levels. Six patients received hormone replacement therapy, with one developing anastomotic leakage after surgery. Notably, cortisol function was normal in all eleven patients preoperatively. All patients exhibited decreased cortisol function postoperatively, and 27% of them experienced irAE during preoperative treatment. Conclusion This case series is the first in the world that reports on gastric cancer patients who developed pituitary insufficiency or cortisol insufficiency after surgery, potentially linked to the combined effects of immunotherapy and surgery. This series emphasizes the importance of monitoring for immune-related adverse events in patients presenting with symptoms such as fatigue, weakness, and hypotension after surgery. Prompt evaluation of pituitary and adrenal cortical function can reduce the risk of complications associated with postoperative cortisol insufficiency, thereby alleviating patient suffering.

Authors

Institutions

Publication Details

Journal
Holistic Integrative Oncology
Published
2026-01-13
DOI
https://doi.org/10.1007/s44178-025-00220-1
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
24.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-gastric cancer surgery hypophysitis and cortisol insufficiency after immunotherapy: a case series

Kan Xue, Fei Shan, Zhouqiao Wu, Minghui Shi et al.
1 citations
Holistic Integrative Oncology
Cancer Immunotherapy and Biomarkers
24.20
article

Post-gastric cancer surgery hypophysitis and cortisol insufficiency after immunotherapy: a case series

Kan Xue, Fei Shan, Zhouqiao Wu, Minghui Shi, Yinkui Wang, Ziyu Li, Shuangxi Li
article en
1 citations

Abstract

Abstract Background Gastric cancer is one of the most prevalent and deadly malignancies worldwide. In recent years, with the development of immune checkpoint inhibitors (such as PD-1/PD-L1 and CTLA-4 inhibitors), immunotherapy has emerged as a new strategy in gastric cancer treatment. However, the incidence of immune-related adverse events (irAEs) has also increased. Here, we report eleven cases of gastric cancer patients who developed pituitary or adrenal cortisol insufficiency in the first postoperative week following neoadjuvant immunotherapy. Case presentation We present a retrospective analysis of patients who underwent surgical resection for gastric cancer at our center starting from December 2023. We evaluated their perioperative cortisol function and identified those who developed perioperative cortisol insufficiency, and identified eleven gastric cancer patients with normal cortisol functions who had received neoadjuvant immunotherapy, and subsequently experienced postoperative changes within a short period following surgery. Among them, six patients showed decreased ACTH and cortisol levels, four patients had reduced cortisol levels, and one patient with no ACTH testing also showed reduced cortisol levels. Six patients received hormone replacement therapy, with one developing anastomotic leakage after surgery. Notably, cortisol function was normal in all eleven patients preoperatively. All patients exhibited decreased cortisol function postoperatively, and 27% of them experienced irAE during preoperative treatment. Conclusion This case series is the first in the world that reports on gastric cancer patients who developed pituitary insufficiency or cortisol insufficiency after surgery, potentially linked to the combined effects of immunotherapy and surgery. This series emphasizes the importance of monitoring for immune-related adverse events in patients presenting with symptoms such as fatigue, weakness, and hypotension after surgery. Prompt evaluation of pituitary and adrenal cortical function can reduce the risk of complications associated with postoperative cortisol insufficiency, thereby alleviating patient suffering.

Holistic Integrative OncologyVol. 5(1)
Peking University (CN), Peking University Cancer Hospital (CN)
Good health and well-being
Openalex Percentile: Top 3%
Cancer Immunotherapy and Biomarkers
24.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.